- Home
- IRON vs LTC Comparison
IRON vs LTC Comparison
Compare IRON & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- LTC
- Stock Information
- Founded
- IRON 2017
- LTC 1992
- Country
- IRON United States
- LTC United States
- Employees
- IRON N/A
- LTC N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- LTC Real Estate Investment Trusts
- Sector
- IRON Health Care
- LTC Real Estate
- Exchange
- IRON Nasdaq
- LTC Nasdaq
- Market Cap
- IRON 2.0B
- LTC 1.7B
- IPO Year
- IRON N/A
- LTC 1992
- Fundamental
- Price
- IRON $59.82
- LTC $36.22
- Analyst Decision
- IRON Strong Buy
- LTC Hold
- Analyst Count
- IRON 10
- LTC 5
- Target Price
- IRON $97.80
- LTC $38.80
- AVG Volume (30 Days)
- IRON 301.7K
- LTC 298.6K
- Earning Date
- IRON 11-11-2025
- LTC 10-27-2025
- Dividend Yield
- IRON N/A
- LTC 6.29%
- EPS Growth
- IRON N/A
- LTC N/A
- EPS
- IRON N/A
- LTC 1.81
- Revenue
- IRON N/A
- LTC $213,197,000.00
- Revenue This Year
- IRON N/A
- LTC N/A
- Revenue Next Year
- IRON N/A
- LTC $30.08
- P/E Ratio
- IRON N/A
- LTC $20.04
- Revenue Growth
- IRON N/A
- LTC 8.74
- 52 Week Low
- IRON $30.82
- LTC $31.70
- 52 Week High
- IRON $68.73
- LTC $39.89
- Technical
- Relative Strength Index (RSI)
- IRON 50.30
- LTC 52.10
- Support Level
- IRON $58.59
- LTC $36.29
- Resistance Level
- IRON $61.27
- LTC $36.68
- Average True Range (ATR)
- IRON 2.13
- LTC 0.45
- MACD
- IRON -0.15
- LTC -0.04
- Stochastic Oscillator
- IRON 18.47
- LTC 35.96
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.